MARC Record from Library of Congress

LEADER: 02221cam a2200397 i 4500
001 2014036380
003 DLC
005 20150627081322.0
008 140915t20152015flu a b 001 0 eng
010 $a 2014036380
020 $a9781482216745 (hardcover : acid-free paper)
020 $a1482216744 (hardcover : acid-free paper)
035 $a(DNLM)101641220
040 $aDNLM/DLC$cDLC$erda$dDLC
042 $apcc
050 00 $aRM301.25$b.S73 2015
060 10 $aQV 785
082 00 $a615.1/9$223
245 00 $aStatistical methods in drug combination studies /$cedited by Wei Zhao and Harry Yang.
264 1 $aBoca Raton :$bCRC Press, Taylor & Francis Group,$c[2015]
300 $axvi, 224 pages :$billustrations ;$c25 cm.
336 $atext$2rdacontent
337 $aunmediated$2rdamedia
338 $avolume$2rdacarrier
490 1 $aChapman & Hall/CRC biostatistics series
500 $a"A Chapman & Hall book."
504 $aIncludes bibliographical references and index.
505 0 $aDrug combination : much promise and many hurdles / Harry Yang and Laura Richman -- Drug combination synergy / Harry Yang, Steven J. Novick, and Wei Zhao -- Drug combination design strategies / Steven J. Novick and John J. Peterson -- Confidence interval for interaction index / Maiying Kong and J. Jack Lee -- Two-stage response surface approaches to modeling drug interaction / Wei Zhao and Harry Yang -- A bayesian industry approach to phase I combination trials in oncology / Beat Neuenschwander, Alessandro Matano, Zhongwen Tang, Satrajit Roychoudhury, Simon Wandel, Stuart Bailey -- Statistical methodology for evaluation combination therapy in clinical trials / H.M. James Hung, Sue-Jane Wang -- Challenges and opportunities in analysis of drug combination clinical trial data / Yaning Wang, Hao Zhu, Liang Zhao, and Ping Ji -- Statistical computational tools for ADA analysis / Cheng Su.
650 12 $aDrug Combinations.
650 22 $aClinical Trials as Topic.
650 22 $aDrug Design.
650 22 $aDrug Therapy, Combination.
650 22 $aModels, Statistical.
700 1 $aZhao, Wei,$d1975- ,$eeditor.
700 1 $aYang, Harry,$eeditor.
830 0 $aChapman & Hall/CRC biostatistics series (Unnumbered)